Inogen (Germany) Today
| 6IO Stock | EUR 6.60 0.05 0.75% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Inogen is trading at 6.60 as of the 28th of March 2025. This is a 0.75 percent decrease since the beginning of the trading day. The stock's lowest day price was 6.6. Inogen has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 22.97 M outstanding shares. More on Inogen Inc
Moving together with Inogen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Inogen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Inogen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Inogen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Nabil Shabshab |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Inogen Inc (6IO) is traded on Frankfurt Exchange in Germany and employs 1,026 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 351.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inogen's market, we take the total number of its shares issued and multiply it by Inogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Inogen Inc classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 22.97 M outstanding shares.
Inogen Inc has accumulated about 249.96 M in cash with (37.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership AllocationInogen Inc has a total of 22.97 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Also note that almost one hundred ninety-nine thousand eight hundred thirty-six invesors are currently shorting Inogen expressing very little confidence in its future performance.
Check Inogen Ownership Details
Inogen Inc Risk Profiles
Although Inogen's alpha and beta are two of the key measurements used to evaluate Inogen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.28 | |||
| Standard Deviation | 5.05 | |||
| Variance | 25.55 | |||
| Risk Adjusted Performance | (0.03) |
Inogen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Inogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Inogen Corporate Directors
| Scott Beardsley | Independent Director | Profile | |
| Heather Rider | Independent Director | Profile | |
| Loren McFarland | Independent Director | Profile | |
| Benjamin AndersonRay | Independent Director | Profile |
Additional Information and Resources on Investing in Inogen Stock
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.